1 / 14

Intramedullary Spinal Cord Lesions in NF1 and NF2

Intramedullary Spinal Cord Lesions in NF1 and NF2. Sheila Kori. NF1. Most common neurocutaneous disorder, autosomal dominant

talbot
Download Presentation

Intramedullary Spinal Cord Lesions in NF1 and NF2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intramedullary Spinal Cord Lesions in NF1 and NF2 Sheila Kori

  2. NF1 • Most common neurocutaneous disorder, autosomal dominant • Pathophysiology: Mutation in or deletion of the NF1 gene, which encodes neurofibromin, leads to tissue proliferation and tumor development. The oligodendrocyte myelin glycoprotein is embedded in this gene which may be the cause of white matter lesions. • Incidence: 1: 3,000-5,000

  3. NF1 • Best Imaging Tool: MRI to evaluate for white matter lesions, visual pathway gliomas, and plexiform lesions • Imaging Findings: • Hyperintense lesions on T2W1 • White Matter lesions involve dentate nuclei of cerebellum, globuspallidus, thalamus, pons, midbrain, hippocampus • Visual pathway gliomas • Sphenoid wing dysplasia • Aneurysms and moyamoya

  4. NF2 • “MISME”: Multiple intracranial schwannomas, meningiomas, ependymomas • Pathophysiology: Mutations in the NF2 gene that encodes merlin which functions as a tumor suppressor. Results in decreased function or production of this protein causing development of tumors in the central and peripheral nervous systems. 50% of patients have NF2 as a result of a new gene mutation. • Incidence: 1: 40,000

  5. NF2 • Best Imaging Tool: Contrast enhanced MR • Imaging Findings: • Bilateral vestibular schwannomas • Meningiomas and schwannomas involving CNs • Spinal manifestations: meningiomas, ependymomas, and nerve sheath tumors

  6. Intramedullary Tumors • Intramedullary lesions are rare, 4-10% of CNS tumors • Are found more commonly in patients with neurofibromatosis: • NF2 associated with ependymomas • NF1 associated with astrocytomas • Some reports of intramedullary schwannomas

  7. Astrocytomas • 75% are well-differentiated grade I, 25% are grade III (anaplastic) lesions • Usually eccentrically located within the cord, since it arises from cord parenchyma, infiltrative • Poorly defined margins, no cleavage plane • Patchy enhancement after intravenous contrast material administration. • T1WI: Iso- to hypointense relative to the spinal cord • T2WI: hyperintense • Average number of vertebral segments involved = 7

  8. Astrocytomas MR T2 (left) and post Gd T1 (right) images show small, cystic, and enhancing astrocytoma.

  9. Ependymomas • Ependymomas are slow growing, displace adjacent neural tissue, and arise from ependymal cells of central canal causing symmetric cord expansion. • T1WI: Iso- or hypointense relative to the spinal cord • T2WI: lesions may be isointense or hyperintense • Most cases (60%) show cord edema around the masses • Average number of vertebral segments involved = 3.6 • 78%–84% of ependymomas have at least one cyst • 84% enhanced after administration of intravenous Gd-based contrasts and (89%) had well-defined margins on post Gd images • NF2 patients with nonsense and frameshift mutations when compared with those of other types of mutations are more likely to have intramedullary tumors but not any other type of tumor.

  10. Ependymomas MR T2 (left) and post Gd T1 (right) images show relatively well-defined cervical ependymoma.

  11. Schwannomas • Most commonly found locations: extradural or intradural extramedullary, however there have been about 60 reports of intramedullary schwannomas. • Pathogenesis is unknown. Some theories include: • Central inclusion of Schwann cells during embryological development • Aberrant Schwann cells around intramedullary myelin fibers • Extension of Schwann cells along the intramedullary perivascular nervous plexus • Transformation of pial cells originating from neuroectoderm into Schwann cells • Tumoral growth of Schwann cells on a dorsal root located in a critical area corresponding to the point where the dorsal root loses its cover and enters the pia mater

  12. Intramedullary Schwannomas • Characteristics on MRI • Well defined margins • Uniform contrast enhancement on post Gd T1WI • Eccentrically located on axial and coronal images • Treatment: complete resection, often likely to cure

  13. Intramedullary Schwannomas MR sagittal (left) and axial (right) T2 images show well-defined, eccentric schwannoma in mid thoracic spinal cord.

  14. References • Barkovich JA. Diagnostic Imaging Pediatric Neuroradiology. 2007; I-8-2 – I-8-9 • Ozawa N, Tashiro T, et al. Subpialschwannoma of the cervical spinal cord mimicking an intramedullary tumor. Radat Med. 2006; 24:690-694 • Patronas NJ, Courcoutsakis N, Bromley CM, et al. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype. Radiology 2001; 218:434 • Egelhoff JC, Bates DJ, et al. Spinal MR finding in neurofibromatosis Types 1 and 2. AJNR. 1992; 13:1071-1077 • KoellerK,Rosenblum, SR, Morrison AL. Neoplasms of the Spinal Cord and FilumTerminale: Radiologic-Pathologic Correlation. RadioGraphics 2000; 20:1721–1749 • Lee M, Rezai, A, Freed D, Epstein F. Intramedullary Spinal Cord Tumors in Neurofibromatosis. Neurosurgery. 1996; 38:32-37

More Related